Strategic expansion Target eGenesis for partnership or sponsorship opportunities at biotech conferences and industry events where they are actively participating, such as BIO International Convention and J.P. Morgan Healthcare Conference, to align with their growth trajectory and funding rounds.

Clinical collaboration Offer collaboration or co-development services with OrganOx and other partners to accelerate regulatory-cleared clinical trials for xenotransplantation products, leveraging their recent FDA-cleared trial steps.

Regulatory readiness Position consultative services around regulatory strategy, trial design, and manufacturing scale-up to support their Series B-funded expansion and commercialization plans in organ shortage solutions.

Bioinformatics & data Propose data management, analytics, and integrated clinical data solutions using their tech stack (MySQL, MariaDB, JSON-LD) to optimize gene-editing platform research, patient matching, and outcome tracking.

Talent & advisory Offer executive and board-level advisory or recruiting services to sustain leadership growth (new board appointments and C-suite hires) and augment capabilities in gene editing, transplantation science, and regulatory affairs.